Abstract | BACKGROUND: OBJECTIVES: We sought to explore the cellular- and molecular-based evidence for the observed clinical benefits. METHODS: Primary cell lines of keloid fibroblasts were treated with 5-FU at a range of lower doses (∼10 mg mL(-1) ) in monolayer culture and subjected to examination for cell viability, proliferative potential, apoptosis, cell cycle and associated proteins involved in cell cycle control. RESULTS:
5-FU significantly inhibited cell proliferation of keloid fibroblasts in the full dose range used in this study. The DNA synthesis was completely inhibited by 5-FU at 72 h, and significant cell apoptosis was observed at concentrations ≥ 1 mg mL(-1) for a period over 72 h. 5-FU caused a significant delay in cell cycle progression and the G2/M phase arrest. 5-FU induced p53 and p21 accumulation together with a decrease in cyclin B1 and Bcl-2 levels in treated keloid fibroblasts. CONCLUSIONS: Our data indicate that low-dose 5-FU (as low as 1 mg mL(-1) ) induces significant inhibition of proliferation, G2/M cell cycle arrest and apoptosis but not immediate cell death of keloid fibroblasts. The lack of tissue necrosis is a particular benefit as further scarring is likely to be prevented. These results support the use of low-dose 5-FU as a potential modality for treating keloid scars.
|
Authors | L Huang, Y P Wong, Y J Cai, I Lung, C S Leung, A Burd |
Journal | The British journal of dermatology
(Br J Dermatol)
Vol. 163
Issue 6
Pg. 1181-5
(Dec 2010)
ISSN: 1365-2133 [Electronic] England |
PMID | 20633010
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2010 The Authors. BJD © 2010 British Association of Dermatologists. |
Chemical References |
- Cell Cycle Proteins
- Immunosuppressive Agents
- Fluorouracil
|
Topics |
- Adolescent
- Adult
- Apoptosis
(drug effects)
- Cell Cycle
(drug effects, physiology)
- Cell Cycle Proteins
(drug effects)
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Child
- Enzyme-Linked Immunosorbent Assay
- Fibroblasts
(drug effects)
- Fluorouracil
(pharmacology)
- G2 Phase
(physiology)
- Humans
- Immunosuppressive Agents
(pharmacology)
- Injections, Intralesional
- Keloid
(drug therapy, metabolism, pathology)
- Young Adult
|